Zirconium-labelled Girentuximab (89ZrTLX250-CDx) PET/CT Imaging for noninvasive diagnosis of Clear Cell Renal Cell Carcinoma: results from the UCLA cohort of the ZIRCON trial
JOURNAL OF NUCLEAR MEDICINE（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要